Hearing to examine Mass. oversight of pharmacies
BOSTON (AP) — Massachusetts legislators are taking a closer look at the state's oversight of a Massachusetts compounding pharmacy that has been linked to a fatal, nationwide outbreak of fungal meningitis.
A hearing Wednesday will consider the state's dealings with Framingham-based New England Compounding Center, which distributed a contaminated steroid that has sickened about 440 people and led to than 30 deaths.
The state pharmacy board is under scrutiny for its handling of past complaints against the company.
Massachusetts Health and Human Services Secretary Judith Bigby, whose department oversees the board, is among those expected to testify.
Also Wednesday, a U.S. House committee hears testimony in Washington from the pharmacy's owner and the state's interim health commissioner. Lawmakers have called for tighter regulation of
compounding pharmacies, which fall into a gray area between state and federal law.
News Photo Galleriesview all
- 90847Read live updates from the May 20 Moore tornado
- 38051Oklahoma devastated by second round of twisters
- 13823Oklahoma City tornado so large, may not be recognized, officials say
- 12196Several kids pulled out of Oklahoma school rubble alive
- 11468How to help tornado victims
- 10241At least 51 die in Oklahoma tornado, official says
- 9606Oklahoma State football: Limiting Wes Lunt's transfer options makes Mike Gundy look bad